AzTrials
AzTrials

Trans Abdominal UltrasoundNCT04687891

Transabdominal Versus Transvaginal Ultrasound to Assess the Thickness of the Lower Uterine Segment.

An observational study of Trans Abdominal Ultrasound and Transvaginal Ultrasound, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

aims to determine the accuracy of measurement of the LUS thickness by trans-abdominal and transvaginal ultrasound at term pregnancy in comparison to the actual thickness of LUS measured with manual caliper measurement during cesarean delivery. Read more about this study

Who is it for?
Ages 20 to 40 years, women only
What is being tested?
transabdominal ultrasound and transvaginal ultrasound
How many people
130 participants
Where
1 siteEgypt
Study dates
1 May 2020to 31 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: 130 pregnant women at term with a previous one cesarean section admitted for an elective cesarean delivery will be enrolled. LUS thickness will be measured using both TVS and TAS prior to the cesarean. The actual thickness of the LUS will be measured using a sterile metal ruler before the neonate had been delivered.

Who may be able to join

  • Age (20:40 years old).
  • Women at term (37:40 weeks).
  • With singleton pregnancy.
  • Presenting by vertex (cephalic presentation).
  • Having adequate liquor.
  • Previous delivered by cesarean delivery one time.

Who cannot join

  • Fetal malformations, e.g fetal hydrops.
  • Uterine malformations, e.g bicornuate uterus.
  • Placental malformations, e.g placenta praevia, placenta accrete.
  • Uterine surgery is other than a cesarean, e.g myomectomy.
  • Women in labor (painful, regular uterine contractions, cervical dilatation, tender scar, and discomfort is not stopped by sedation).
  • Obese patients (BMI >30 kg/m2)

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • faculty of medicine - Cairo university

    Cairo, Kasr El Ainy, 11562

Other trials in Egypt

About this study

Official title: Transabdominal Versus Transvaginal Ultrasound to Assess the Thickness of the Lower Uterine Segment at Term in Women With Previous One Cesarean Section.

aims to determine the accuracy of measurement of the LUS thickness by trans-abdominal and transvaginal ultrasound at term pregnancy in comparison to the actual thickness of LUS measured with manual caliper measurement during cesarean delivery.

Study hypothesis: In women with previous cesarean delivery, determination of the LUS thickness can be done by trans-abdominal and transvaginal ultrasound at term pregnancy and compared to the actual thickness of LUS measured with a manual caliper at cesarean delivery.

Study question: considering transabdominal \& transvaginal ultrasound, which of them would be more accurate in the assessment of LUS thickness?

Being tested
transabdominal ultrasound and transvaginal ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transabdominal ultrasound and transvaginal ultrasoundDiagnostic test

    Within a week before scheduled delivery,antepartum transabdominal and transvaginal ultrasound will be performed with moderately full bladder.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. accuracy test for measuring

    The accuracy of measurement of the LUS thickness by trans-abdominal and transvaginal ultrasound at term pregnancy in comparison to actual thickness of LUS measured with manual caliper at cesarean delivery.

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2020
  2. Study start1 May 2020
  3. Primary completion30 Dec 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04687891
Sponsor's protocol ID
35/2020
Status last verified
Jul 2021
First submitted
24 Dec 2020
Last updated
29 Jul 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Nagy Afifi A, Ahmed Taymour M, Mamdouh El-Khayat W. Transabdominal versus transvaginal ultrasound to assess the thickness of lower uterine segment at term in women with previous cesarean section. Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:145-151. doi: 10.1016/j.ejogrb.2022.01.027. Epub 2022 Feb 7.

    PubMed 35203047

Questions about this trial

What is this clinical trial studying?

An observational study of Trans Abdominal Ultrasound and Transvaginal Ultrasound, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

accuracy test for measuring (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04687891, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in